Skip to main content
Clinical Trials/NCT05153655
NCT05153655
Completed
Not Applicable

Safety and Tolerability of Local Ischemic Post-conditioning in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy

Capital Medical University1 site in 1 country18 target enrollmentDecember 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Ischemic Stroke
Sponsor
Capital Medical University
Enrollment
18
Locations
1
Primary Endpoint
Number of participants with major response
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Ischemic post-conditioning is a neuroprotective strategy that has been proven to attenuate reperfusion injury in animal models of stroke. The purpose of this proof-of-concept study is to determine the safety and tolerability of ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

Registry
clinicaltrials.gov
Start Date
December 15, 2021
End Date
August 15, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Capital Medical University
Responsible Party
Principal Investigator
Principal Investigator

Ji Xunming,MD,PhD

Professor

Capital Medical University

Eligibility Criteria

Inclusion Criteria

  • Age 18-80 years;
  • Acute ischemic stroke caused by middle cerebral artery M1 segment occlusion;
  • Successful recanalization (mTICI 2b/3) after endovascular thrombectomy that confirmed by digital subtraction angiography;
  • Written informed consent provided by the patients or their legal relatives.

Exclusion Criteria

  • Known diagnosis or clinical suspicion of cerebral vasculitis or fibromuscular dysplasia;
  • Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
  • Stenting in the middle cerebral artery as rescue therapy during the thrombectomy procedures;
  • \> 2 times of balloon dilations as rescue therapy due to angioplasty during the thrombectomy procedures;
  • Moderate or severe residual stenosis (≥ 50%) of the culprit artery after recanalization;
  • Difficulty in complying with ischemic post-conditioning or other conditions that the investigator considered inappropriate for inclusion.

Outcomes

Primary Outcomes

Number of participants with major response

Time Frame: Immediately after intervention on the day of ischemic post-conditioning

Major response is any of the following: * Vessel perforation or rupture; * Reocclusion of the culprit vessel after post-conditioning; * Vessel dissection; * Severe vasospasm; * Ischemic post-conditioning related thrombotic events; * Rupture of the balloon used for post-conditioning. In the 3 + 3 design, 3 subjects are recruited for a given ischemic post-conditioning dose level. The trial is stopped if ≥ 2 of 3 subjects at a given dose level show major response. If only 1 of 3 subjects shows major response, 3 more subjects are recruited at a given dose level and a major response in any of them will stop the trial. Otherwise, same procedure is followed for the next ischemic post-conditioning dose level. Maximum tolerable dose will be the dose at the level before stopping of the trial.

Study Sites (1)

Loading locations...

Similar Trials